What is the price of Adamis Pharmaceuticals Corporation (ADMP)

The price of Adamis Pharmaceuticals Corporation (ADMP) is $0.6241

What is the market cap of Adamis Pharmaceuticals Corporation (ADMP)

The market cap of Adamis Pharmaceuticals Corporation (ADMP) is $836.88K

Adamis Pharmaceuticals Corporation (ADMP) Shares Outstanding

Adamis Pharmaceuticals Corporation is a specialized biopharmaceutical company primarily engaged in the development and commercialization of products within the United States, targeting key therapeutic domains such as allergy, opioid overdose, respiratory conditions, and inflammatory diseases. Its current product portfolio includes SYMJEPI pre-filled epinephrine syringes for the emergency treatment of severe allergic reactions, including anaphylaxis; dry powder inhaler products designed for asthma management; and injectable naloxone for addressing opioid overdose. Additionally, Adamis is advancing pipeline candidates such as APC400, a tempol gel aimed at mitigating radiation-induced dermatitis in cancer patients, and APC410, formulated to treat a range of respiratory ailments including asthma, respiratory syncytial virus (RSV), influenza, and COVID-19. The company also extends its offerings to include corticosteroids, hormone replacement therapies, hospital outsourcing products, and other injectables, alongside a line of veterinary pharmaceutical products. Established in 2006, Adamis Pharmaceuticals Corporation maintains its headquarters in San Diego, California.

Year	Shares Outstanding	Change
Not enough data for the provided dates.

Year

Shares Outstanding

Change

Not enough data for the provided dates.

Company	Shares Outstanding	Difference	Country
MERCK Kommanditgesellschaft auf Aktien MER.SW	-	-	DE
Merck KGaA MRK.DE	-	-	DE
Takeda Pharmaceutical Company Limited 4502.T	-	-	JP
Galderma Group AG GALD.SW	-	-	CH
Sun Pharmaceutical Industries Limited SUNPHARMA.NS	2.40B	-	IN

Company

Shares Outstanding

Difference

Country